Asian Journal Of Social Pharmacy

Abstract: Objective To analyze the development status of contract development manufacturing organization (CDMO) at home and abroad, and to make some suggestions for the development of CDMO in China. Methods The relevant literature was searched and reviewed, and the development status of CDMOs in the United States, France, Japan and China was compared from the aspects of market scale, development process, development focus, advantages and disadvantages, and policy support. Then, some suggestions for the development of CDMO enterprises in China were summarized. Results and Conclusion Through the comparison of CDMO development at home and abroad, it can be seen that China started CDMO late, there were many technical barriers and its globalization layout were not sufficient. However, the development trend was good and it focused on the field of chemical drugs and biological drugs to constantly develop innovative drugs. China needs to continuously improve its own technical capabilities to carry out innovative research. Therefore, cost reduction and efficiency increase will be the key elements for the development of CDMOs, and they are expected to have a rapid and comprehensive development in the future.

Key words: